COPD - Nationale VersorgungsLeitlinien

223. Tarpy SP,Celli BR. Long-term oxygen therapy. N Engl J Med 1995;333(11):710-4.
224. Heaney LG, McAllister D, MacMahon J. Cost minimisation analysis of provision of oxygen at home:
are the drug tariff guidelines cost effective? BMJ 1999;319(7201):19-23.
225. Pelletier-Fleury N, Lanoe JL, Fleury B, Fardeau M. The cost of treating COPD patients with long-term
oxygen therapy in a French population. Chest 1996;110(2):411-6.
226. Köhler D, Criee CP, Raschke F. Leitlinien zur häuslichen Sauerstoff- und Heimbeatmungstherapie.
Deutsche Gesellschaft für Pneumologie (DGP), Deutsche Gesellschaft für Schlafmedizin (DGSM),
Arbeitsgruppe Nächtliche Atmungs- und Kreislaufstörungen (AGNAK), Arbeitskreis Heim- und
Langzeitbeatmung. Pneumologie 1996;50(12):927-31.
227. Simonds AK,Elliott MW. Outcome of domiciliary nasal intermittent positive pressure ventilation in
restrictive and obstructive disorders. Thorax 1995;50(6):604-9.
228. Meecham Jones DJ, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus
oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med
1995;152(2):538-44.
229. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to
restrictive lung disease, COPD, and nocturnal hypoventilation--a consensus conference report.
Chest 1999;116(2):521-34.
230. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy
in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106(2):196-204.
231. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Anto JM. Patients hospitalized for
COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir
J 2000;16(6):1037-42.
232. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117(5
Suppl 2):S398-401.
233. Anderson HR, Spix C, Medina S, Schouten JP, Castellsague J, Rossi G, Zmirou D, Touloumi G,
Wojtyniak B, Ponka A, Bacharova L, Schwartz J, Katsouyanni K. Air pollution and daily admissions
for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur
Respir J 1997;10(5):1064-71.
234. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade
TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory
markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit
Care Med 2001;164(9):1618-23.
235. Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient
management of acute exacerbations of COPD. Chest 2000;117(6):1638-45.
236. Tellez-Rojo MM, Romieu I, Ruiz-Velasco S, Lezana MA, Hernandez-Avila MM. Daily respiratory
mortality and PM10 pollution in Mexico City: importance of considering place of death. Eur Respir J
2000;16(3):391-6.
237. Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S.
Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute
bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Clin Infect Dis
1998;27(4):722-9.
238. Emerman CL, Connors AF, Lukens TW, Effron D, May ME. Relationship between arterial blood
gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease. Ann Emerg
Med 1989;18(5):523-7.
© 2006
92